Psychiatric symptoms in migraine patients and their attitudes towards psychological support on stigmatization

Korkmaz, Sevda; Kazğan, Aslı; Korucu, Tuba; Gönen, Murat; YİLMAZ>, Mehmet; Atmaca, Murad

doi:10.1016/j.jocn.2018.11.035

Cited by 10 publications

(12 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While no CTh studies have been conducted to explore headache phase-related cortical plasticity in migraine. An extensive literature has shown that a wide range of psychiatric disorders, especially anxiety and depression, can accompany migraine [4,[47][48][49]. Previous studies revealed cortical abnormalities in depression [35,50,51] and anxiety disorders [52][53][54][55].…”

Section: Discussionmentioning

confidence: 99%

Cortical thickness in migraine: a coordinate-based meta-analysis

Sheng

Shi³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Cortical thickness (CTh) analysis is a popular method to characterize brain morphometry. Many studies have been performed to investigate CTh abnormalities in migraine. However, the results from these studies were not consistent and even conflicting. These divergent results hinder us from obtaining a clear picture of brain morphometry regarding CTh alterations in migraine. Coordinate-based meta-analysis (CBMA) is a promising technique to quantitatively pool individual neuroimaging studies to identify consistent brain areas involved. Methods Electronic databases (PubMed, Embase, Web of Science, China National Knowledge Infrastructure, WanFang, and SinoMed) and other sources (bioRxiv and reference lists of relevant articles and reviews) were systematically searched for studies that compared regional CTh differences between patients with migraine and healthy controls (HCs) up to May 15, 2020. A CBMA was performed using the Seed-based d Mapping with Permutation of Subject Images (SDM-PSI) approach. Results In total, we identified 16 studies with 17 datasets reported that were eligible for the CBMA. The 17 datasets included 872 patients with migraine (average sample size 51.3, mean age 39.6 years, 721 females) and 949 HCs (average sample size 59.3, mean age 44.2 years, 680 females). The CBMA detected no statistically significant consistency of CTh alterations in patients with migraine relative to HCs. Sensitivity analysis and subgroup analysis verified this result to be robust. Meta-regression analyses revealed that this CBMA result was not confounded by age, gender, aura, attack frequency per month, and illness duration. Conclusions Our CBMA adds to the evidence of the replication crisis in neuroimaging research that is increasingly recognized. The current evidence suggests that CTh is not a reliable biomarker of migraine. Many potential confounders, such as underpowered sample size, heterogeneous patient selection criteria, and differences in imaging collection and methodology, may contribute to the inconsistencies of CTh alterations in migraine, which merit attention before planning future research on this topic.

show abstract

Section: Discussionmentioning

confidence: 99%

Cortical thickness in migraine: a coordinate-based meta-analysis

Sheng

Shi³

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The disability picture emerging from those data confirms the relevance of assessing psychological distress, psychiatric comorbidities and quality of life in patients with CM when attending healthcare services for receiving prophylactic treatment using OnabotulinumtoxinA. Indeed, psychological distress is often under-recognized and untreated, and patients with migraine often do not report psychological distress or psychiatric symptoms in the clinical encounter [42]. The continuity of OnabotulinumtoxinA treatment administration overtime for several months might contribute to easing the assessment of psychological distress of patients and referring them, if needed, to psychological treatment.…”

Section: Discussionmentioning

confidence: 80%

A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment

Gandolfi

Donisi

Marchioretto

et al. 2019

Toxins

View full text Add to dashboard Cite

Chronic Migraine (CM) is a disabling neurologic condition with a severe impact on functioning and quality of life. Successful therapeutic management of patients with CM is complex, and differences in therapeutic response could be attributable to genetically determined factors, sensitivity to pharmacological treatment, psychosocial and relational factors affecting the patient’s compliance and approach on the therapeutic treatment. The aim of this prospective observational study was to explore self-efficacy, coping strategies, psychological distress and headache-related disability in a cohort of 40 patients with CM (mean age: 46.73; standard deviation 13.75) treated with OnabotulinumtoxinA and the relationship between these clinical and psychological aspects and acute medication consumption during OnabotulinumtoxinA prophylactic treatment. Patients presented an overall significant reduction in the Headache Index (HI) (p < 0.001), HI with severe intensity (p = 0.009), and total analgesic consumption (p = 0.003) after the prophylactic treatment. These results are in line with the literature. Despite this, higher nonsteroidal anti-inflammatory drugs consumption was associated with higher psychological distress, higher HI with severe and moderate intensity, and worse quality of life. Conversely, triptans consumption was correlated with HI of mild intensity, and problem-focused coping strategies. To conclude, the psychological profile, and in particular, the psychological distress and specific coping strategies might influence the self-management of acute medication.

show abstract

“…However, no CTh studies to date have been conducted to explore headache phase-related cortical plasticity in migraine. An extensive literature has shown that a wide range of psychiatric disorders, especially anxiety and depression, can accompany migraine (Minen et al, 2016;Seng and Seng, 2016;Bergman-Bock, 2018;Korkmaz et al, 2019). Previous studies revealed cortical abnormalities in depression (Schmaal et al, 2017;Suh et al, 2019;Li et al, 2020) and anxiety disorders (Zhao et al, 2017;Molent et al, 2018;Carnevali et al, 2019;Suffren et al, 2019).…”

Section: Discussionmentioning

confidence: 99%

Cortical Thickness in Migraine: A Coordinate-Based Meta-Analysis

Sheng

Shi

et al. 2021

Front. Neurosci.

View full text Add to dashboard Cite

Cortical thickness (CTh) via surface-based morphometry analysis is a popular method to characterize brain morphometry. Many studies have been performed to investigate CTh abnormalities in migraine. However, the results from these studies were not consistent and even conflicting. These divergent results hinder us to obtain a clear picture of brain morphometry regarding CTh alterations in migraine. Coordinate-based meta-analysis (CBMA) is a promising technique to quantitatively pool individual neuroimaging studies to identify consistent brain areas involved. Electronic databases (PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure, WanFang, and SinoMed) and other sources (bioRxiv and reference lists of relevant articles and reviews) were systematically searched for studies that compared regional CTh differences between patients with migraine and healthy controls (HCs) up to May 15, 2020. A CBMA was performed using the Seed-based d Mapping with Permutation of Subject Images approach. In total, we identified 16 studies with 17 datasets reported that were eligible for the CBMA. The 17 datasets included 872 patients with migraine (average sample size 51.3, mean age 39.6 years, 721 females) and 949 HCs (average sample size 59.3, mean age 44.2 years, 680 females). The CBMA detected no statistically significant consistency of CTh alterations in patients with migraine relative to HCs. Sensitivity analysis and subgroup analysis verified this result to be robust. Metaregression analyses revealed that this CBMA result was not confounded by age, gender, aura, attack frequency per month, and illness duration. Our CBMA adds to the evidence of the replication crisis in neuroimaging research that is increasingly recognized. Many potential confounders, such as underpowered sample size, heterogeneous patient selection criteria, and differences in imaging collection and methodology, may contribute to the inconsistencies of CTh alterations in migraine, which merit attention before planning future research on this topic.

show abstract

Psychiatric symptoms in migraine patients and their attitudes towards psychological support on stigmatization

Cited by 10 publications

References 15 publications

Cortical thickness in migraine: a coordinate-based meta-analysis

Cortical thickness in migraine: a coordinate-based meta-analysis

A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment

Cortical Thickness in Migraine: A Coordinate-Based Meta-Analysis

Contact Info

Product

Resources

About